CIRculating CANcer MAster-Protocol

Recruiting now

Conditions studied: Adult With Solid Cancer

In brief

This exploratory study will focus on the development of the analyses of blood biomarkers to better understand the circulating biomarkers associated with cancer diagnosis, treatment efficacy and progressive disease

Key facts

Study ID

NCT05089747

Run by

Hospices Civils de Lyon

People needed

6000

Starts

2022-12-05

Expected to finish

2047-12-01

Last updated by the study team

2026-06-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult (>18y)
• Owing a social security insurance
• Any solid cancer diagnosed by histopathology or cytology
• Patient with blood sampling required as per standard of care
• Informed consent signed

You may not qualify if…

• Refusal to participate
• No blood sampling required as per standard of care
• Hemoglobin < 7g/dl (< 9g/dl if respiratory or cardiovascular disease history)
• Heterologous blood transfusion in the last 48 hours
• Weight under 20 kg

Where it is running

• Service de Pneumologie Hôpital Louis Pradel / Groupement Hospitalier Est — Bron, France (enrolling)
• Hôpital Edouard Herriot / Groupement Hospitalier Centre — Lyon, France (enrolling)
• Service de Pneumologie Hôpital Croix-Rousse / Groupement Hospitalier Nord — Lyon, France (enrolling)
• Service de Pneumologie Aigue Spécialisée et Cancérologie Thoracique Hôpital Lyon-Sud / Groupement Hospitalier Sud — Pierre-Bénite, France (enrolling)
• Hôpital Lyon-Sud / Groupement Hospitalier Sud — Pierre-Bénite, France (enrolling)
• Oncologie médicale Hôpital Lyon-Sud / Groupement Hospitalier Sud — Pierre-Bénite, France (enrolling)
• Service de dermatologie Hôpital Lyon-Sud / Groupement Hospitalier Sud — Pierre-Bénite, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.